Long-term survival of a patient with giant cell glioblastoma. Case report.

The authors report on a patient who had undergone resection of a left-sided temporal giant cell glioblastoma at the age of 69 years and who survived for more than 17 years. This man had not undergone postoperative radiotherapy or adjuvant chemotherapy. He died at the age of 86 years without clinical evidence of tumor recurrence. Histologically, the lesion was characterized by highly pleomorphic tumor cells (including bizarre multinucleated giant cells) with high mitotic activity, large necroses, and prominent mononuclear infiltration. A point mutation in the TP53 tumor suppressor gene (c.524G>A; R175H) and no epidermal growth factor receptor gene amplification were revealed on molecular genetic analysis. No diagnostic chromosomal imbalances were identified on comparative genomic hybridization, although the average ratio profile for chromosome 10 indicated loss of 10p15 in a subpopulation of tumor cells. This patient is exceptional because tumor resection, probably in conjunction with a marked antitumor immune response, apparently resulted in eradication of the lesion.

[1]  J. Cairncross,et al.  Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study , 1999, Annals of neurology.

[2]  D. Brat,et al.  Pleomorphic xanthoastrocytoma , 1999, Cancer.

[3]  Y. Yonekawa,et al.  Genetic profile of the giant cell glioblastoma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[4]  W. Roggendorf,et al.  Favorable outcome of giant cell glioblastoma in a child Report of an 11-year survival period , 1998, Child's Nervous System.

[5]  K. Ichimura,et al.  Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades , 1998, Genes, chromosomes & cancer.

[6]  S. Leenstra,et al.  Genetic sub‐types of human malignant astrocytoma correlate with survival , 1998, International journal of cancer.

[7]  T. Sekiya,et al.  Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas , 1998, Oncogene.

[8]  P. Lunardi,et al.  Long-Term Survival in Cerebral Glioblastoma. Case Report and Critical Review of the Literature , 1998, Tumori.

[9]  S. Bigner,et al.  Molecular Cytogenetics of Brain Tumors , 1997, Journal of neuropathology and experimental neurology.

[10]  K. Plate,et al.  p53 Mutations versus EGF Receptor Expression in Giant Cell Glioblastomas , 1997, Journal of neuropathology and experimental neurology.

[11]  G. Reifenberger,et al.  Molecular genetic analysis of giant cell glioblastomas. , 1997, The American journal of pathology.

[12]  A. Markoe,et al.  Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. , 1997, International journal of radiation oncology, biology, physics.

[13]  C. Sommer,et al.  Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. , 1996, Oncogene.

[14]  G. Reifenberger,et al.  Analysis of p53 Mutation and Epidermal Growth Factor Receptor Amplification in Recurrent Gliomas with Malignant Progression , 1996, Journal of neuropathology and experimental neurology.

[15]  P. Pahapill,et al.  Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. , 1996, Neurosurgery.

[16]  Cairncross Jg,et al.  Treatment of malignant glioma in adults , 1995 .

[17]  S. Leenstra,et al.  Human malignant astrocytes express macrophage phenotype , 1995, Journal of Neuroimmunology.

[18]  M R Speicher,et al.  Quantitative analysis of comparative genomic hybridization. , 1995, Cytometry.

[19]  M. Prados,et al.  Long-term survival in patients with glioblastoma multiforme. , 1993, Neurosurgery.

[20]  R. Selker,et al.  Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. , 1992, Surgical neurology.

[21]  N. de Tribolet,et al.  Long-time survival of a patient with glioblastoma and Turcot's syndrome. Case report. , 1991, Journal of neurosurgery.

[22]  M. Esiri,et al.  HLA-Dr Expression by Tumor Cells Compared with Survival in High Grade Astrocytomas , 1991, Tumori.

[23]  G. Reifenberger Immunhistochemie der Tumoren des Nervensystems , 1991 .

[24]  N. Vick,et al.  Effects of treatment on long‐term survivors with malignant astrocytomas , 1990, Annals of neurology.

[25]  L. Akslen,et al.  Giant cell glioblastoma: a work‐up of 2 cases with long survival , 1989, Acta neurologica Scandinavica.

[26]  U. Kalyan-Raman,et al.  Giant‐celled glioblastoma of brain. A clinico‐pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure) , 1989, Cancer.

[27]  L. Salford,et al.  Ten-year survival among patients with supratentorial astrocytomas grade III and IV. , 1988, Journal of neurosurgery.

[28]  P. Bucy,et al.  Cerebral glioblastomas can be cured! , 1985, Neurosurgery.

[29]  N. de Tribolet,et al.  Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. , 1985, European journal of cancer & clinical oncology.

[30]  M. Fukui,et al.  CT findings in patients with gliomas, surviving more than 10 years. , 1984, Neurochirurgia.

[31]  D. Groothuis,et al.  Pleomorphic xanthoastrocytoma. Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery , 1983, Cancer.

[32]  A. Johnson Malignant intracranial tumor: report of three cases with long-term postoperative survival. , 1981, Surgical neurology.

[33]  P. Burger,et al.  Histologic factors of prognostic significance in the glioblastoma multiforme , 1980, Cancer.

[34]  L. Eng,et al.  Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis A study of 12 cases , 1979, Cancer.

[35]  E. Lobsiger,et al.  [Unusually long survival time in astrocytoma grade III--IV (author's transl)]. , 1977, Der Nervenarzt.

[36]  U. Roessmann,et al.  Glial origin of monstrocellular tumor. Case report of prolonged survival. , 1967, Journal of neurosurgery.

[37]  B. M. Barone,et al.  LONG-TERM POSTOPERATIVE SURVIVAL IN TWO CASES OF GLIOBLASTOMA MULTIFORME. , 1965, Journal of neurosurgery.

[38]  J G ROTH,et al.  Glioblastoma multiforme: a clinical survey. , 1960, Journal of neurosurgery.

[39]  M. Netsky,et al.  The longevity of patients with glioblastoma multiforme. , 1950, Journal of neurosurgery.